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Abstract
Background: To evaluate the relative chemopreventive efficacy of two black tea polyphenols,
Polyphenon-B [P-B] and BTF-35 on 7,12-dimethylbenz [a]anthracene (DMBA)-induced hamster
buccal pouch (HBP) carcinogenesis.
Methods: Hamsters were divided into 6 groups. The right buccal pouches of animals in groups 1–3
were painted with 0.5% of DMBA three times a week for 14 weeks. While hamsters in group 1
received no further treatment, animals in groups 2 and 3 received diet containing 0.05% P-B and
BTF-35 respectively, four weeks before DMBA painting that was continued until the end of the
experiments. Animals in groups 4 and 5 were given P-B and BTF-35 alone respectively as in groups
2 and 3. Group 6 animals served as the untreated control. All the animals were sacrificed after 18
weeks. The expression of p21, cyclin D1, glutathione S-transferase pi (GST-P), nuclear factor kappa
B (NF-κB), Bcl-2, Bax, cytochrome C, caspase-3, caspase-9, poly(ADP-ribose) polymerase (PARP),
cytokeratins and vascular endothelial growth factor (VEGF) was analysed by RT-PCR,
immunohistochemical and Western blot analyses.
Results: DMBA treated animals developed buccal pouch carcinomas that displayed increased
expression of p21, cyclin D1, GST-P, NF-κB, cytokeratins, VEGF and Bcl-2 with decreased
expression of Bax, cytochrome C, caspase-3, caspase-9, and PARP. Dietary administration of both
P-B and BTF-35 reduced the incidence of DMBA-induced HBP carcinomas by modulating markers
of cell proliferation, cell survival, tumour infiltration, angiogenesis, and apoptosis.
Conclusion: The results of the present study provide a mechanistic basis for the chemopreventive
potential of black tea polyphenols. The greater efficacy of BTF-35 in inhibiting HBP carcinogenesis
and modulating multiple molecular targets may have a potential role in the prevention of oral
cancer.
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Background
Oral squamous cell carcinoma (OSCC), the fifth most
common cancer worldwide is a major cause of morbidity
and mortality in India [1]. Recent efforts to control the
incidence of OSCC have focused on developing effective
chemoprevention strategies. However, it is important to
establish chemoprevention in an experimental animal
tumour model that mimics specific characteristics of
human OSCC.
The hamster buccal pouch (HBP) carcinogenesis model is
the most well characterized animal system for the investi-
gation of oral cancer development and intervention by
chemopreventive agents. The buccal pouch of the Syrian
hamster serves as an excellent target organ for chemointer-
vention because of easy accessibility for examination and
follow-up of lesions. Squamous cell carcinoma (SCC)
induced by 7,12-dimethylbenz [a]anthracene (DMBA) in
the HBP reiterates many of the features observed in
human OSCC. Topical application of DMBA to the HBP
induces SCC preceded by hyperplasia, papilloma and dys-
plasia similar to human OSCC [2]. The major risk factors
associated with human oral cancer such as tobacco, betel
quid and alcohol also promote HBP carcinogenesis [3,4].
The development of both OSCC and HBP carcinomas is
associated with sustained genetic mutations that lead to
excessive cell proliferation, prolonged cell survival, dys-
regulation of cellular differentiation and evasion of apop-
tosis [2]. The similarities between human OSCC and HBP
carcinomas provide a rationale for analyzing the effect of
putative chemopreventive agents in the HBP model. We
have used this model extensively in this laboratory to test
the chemopreventive efficacy of several medicinal plants,
phytochemicals and dietary agents [5,6].
Chemoprevention by dietary agents has evolved as an
effective strategy to control the incidence of oral cancer.
Epidemiological studies have demonstrated a positive
correlation between increased consumption of vegetables,
fruits and beverages with reduced risk of cancer [7,8].
Recently, a great deal of attention has been focused on tea
made from the leaves of Camellia sinensis. About 3 billion
kilograms of tea are produced and consumed annually, of
which black tea accounts for nearly 80 per cent. Several
studies have demonstrated the protective effects of black
tea against chronic diseases such as cardiovascular disease
and cancer [8,9]. The predominant consumption of black
tea has intensified global interest to evaluate the protec-
tive effect of black tea and its constituents against carcino-
genesis.
Black tea is known to exhibit a wide spectrum of pharma-
cological effects including antioxidant, antiproliferative,
anti-inflammatory and immunomodulatory properties
[8]. In previous reports from this laboratory, we docu-
mented the chemopreventive potential of a mixture of
black tea polyphenols (Polyphenon-B; [P-B]) both alone
and in combination with bovine lactoferrin in the HBP
carcinogenesis model [10]. We have also demonstrated
the inhibitory effects of P-B on rat mammary and stomach
carcinogenesis models [11,12]. The present study was
designed to compare the chemopreventive potential of
polyphenon- B with BTF-35, a black tea extract enriched
with theaflavins and catechins, in the HBP model. Since
no single marker can fully elucidate the mechanism
underlying chemoprevention, we analysed the expression
of a panel of markers that are reliable indicators of cell
proliferation and survival (p21, cyclin D1, glutathione S-
transferase pi; GST-P, and nuclear factor kappa B; NF-κB),
apoptosis (Bcl-2, Bax, cytochrome C, caspase-3, caspase-9,
and poly(ADP-ribose) polymerase; PARP), as well as
tumour invasion and angiogenesis (cytokeratins and vas-
cular endothelial growth factor, VEGF) by RT-PCR, immu-
nohistochemical, and Western blot analyses. In addition,
the activity of caspase-3 was assayed by a colorimetric
method. Our results indicate that BTF-35 is a more potent
inhibitor of HBP carcinogenesis based on suppression of
HBP carcinomas and modulation of markers of cell prolif-
eration, cell survival, tumour infiltration, angiogenesis
and apoptosis.
Methods
Chemicals
DMBA was purchased from Sigma Chemical Company,
St. Louis, MO, USA. P-B and BTF-35 were kindly provided
by Mitsui Norin Co., Ltd., Tokyo, Japan. The composition
of P-B and BTF-35 are given in Table 1. All other reagents
used were of analytical grade.
Animals
The experiment was carried out with male Syrian hamsters
aged 6–10 weeks weighing between 90–110 g obtained
from the Central Animal House, Annamalai University,
Table 1: Composition of P-B and BTF-35
Polyphenolic constituent P-B (%w/w) BTF-35 (%w/w)
Epigallocatechin (EGC) - 0.1
Epicatechin (EC) 0.4 0.2
Epigallocatechin gallate (EGCG) 1.4 2.6
Epicatechin gallate (ECG) 0.1 2.1
Gallocatechin gallate (GCG) 0.2 0.3
Catechin gallate (CG) - 0.1
Catechin (C) - 0.1
Free theaflavin 0.32 7.1
Theaflavinmonogallate-A 0.14 8.3
Theaflavinmonogallate-B 0.15 2.6
Theaflavindigallate 0.24 9.8
Tannin 35.6 -
Caffeine 4.9 0.5Journal of Carcinogenesis 2007, 6:19 http://www.carcinogenesis.com/content/6/1/19
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India. The animals were housed six to a polypropylene
cage and provided food and water ad libitum. The animals
were maintained in a controlled environment under
standard conditions of temperature and humidity with an
alternating 12-hours light/dark cycle. The animals were
maintained in accordance with the guidelines of the
Indian Council of Medical Research and approved by the
ethical committee, Annamalai University. Experimental
diet was prepared everyday by mixing P-B and BTF-35 to
preweighed standard pellet diet (Mysore Snack Feed, Mys-
ore, India). The diet was replenished everyday and the
food consumption was recorded.
Treatment schedule
The hamsters were randomized into experimental and
control groups and divided into 6 groups of 6 animals
each. At 10 weeks of age, the hamsters in groups 1 to 3
were painted with a 0.5% solution of DMBA in liquid par-
affin on the right buccal pouches using a number 4 brush
three times a week for 14 weeks. Each application leaves
approximately 0.4 mg DMBA [2]. Hamsters in group 1
received no further treatment. Animals in groups 2 and 3
received diet containing P-B and BTF-35 respectively four
weeks before DMBA painting when they were 6 weeks of
age and continued until the final exposure to carcinogen.
Animals in groups 4 and 5 were given P-B and BTF-35
alone respectively as in groups 2 and 3. Group 6 animals
received basal diet and served as control. The dose for
black tea polyphenols used in the present study corre-
sponds to the daily intake of four cups of tea (30–40 mg
of tea polyphenols per kilogram body weight by humans)
[13]. The experiment was terminated at the end of 18
weeks and all animals were sacrificed by cervical disloca-
tion after an overnight fast. Before an animal was killed,
the right buccal pouch was grossly inspected to evaluate
premalignant lesions or tumour development and photo-
graphed. The tumour burden was calculated by multiply-
ing the mean tumour volume (4/3 πr3) (r = 1/2 tumour
diameter in mm) with the mean number of tumours. The
buccal pouch tissues were subdivided and variously proc-
essed for distribution to each experiment. A portion of the
tissue was immediately frozen in liquid nitrogen for sub-
sequent RNA extraction and another portion was proc-
essed using lysis buffer for Western blot analysis. The
remaining tissues were fixed in 10% formalin, embedded
in paraffin, sectioned and mounted on polylysine-coated
glass slides. One section from each specimen was stained
with haematoxylin and eosin. The other sections were
used for immunohistochemical staining.
Immunohistochemistry
The tissue sections on glass slides were deparaffinised by
heat at 60°C for 30 minutes, followed by three washes in
xylene. After gradual hydration through graded alcohol,
the slides were incubated in citrate buffer (pH 6.0) for two
cycles of 5 minutes in a microwave oven for antigen
retrieval. The sections were allowed to cool for 20 min-
utes, rinsed with Tris-buffered saline (TBS) and treated
with 3% H2O2 in distilled water for 15 minutes to inhibit
endogenous peroxidase activity. Nonspecific antibody
binding was reduced by incubating the sections with nor-
mal goat serum for 25 minutes. The sections were then
incubated with mouse monoclonal antibodies against
cytokeratin AE1/AE3, Bcl-2 (Dako, Carprinteria, CA,
USA), caspase-3, cytochrome C (NeoMarkers, USA), p21,
VEGF (Santa Cruz Biotechnology, CA, USA), and rabbit
polyclonal antibodies against GST-P (BioGenex, San
Raman, CA, USA), NF-κB and Bax (Santa Cruz Biotech-
nology) at room temperature for one hour. The slides
were rinsed in TBS and incubated with anti-mouse and
anti-rabbit biotin-labelled secondary antibody (DAKO)
followed by streptavidin-biotin-peroxidase for 30 min-
utes each at room temperature. The immunoprecipitate
was visualized by treating with 3,3'-diaminobenzidine
(DAKO) and counterstaining with haematoxylin. For neg-
ative controls, the primary antibody was replaced with
TBS. Positive controls for each antibody were also proc-
essed simultaneously.
Immunohistochemical staining was scored according to
the number of positively stained cells per 100 counted
cells. Immunoreactivity of p21, GST-P, NF-κB, Bcl-2, Bax,
cytochrome C, caspase-3 and VEGF was regarded as nega-
tive (0) when there was no staining; weak (1) when the
staining was focal and mildly intense; moderate (2) when
between two-third of cells stained moderately; and strong
(3) when the majority of cells (> two third) stained
intensely. Cytokeratin expression was graded as 0 = failure
to detect the keratin, I = staining confined either to the
basal area or some evidence of suprabasal staining, II =
positive staining throughout the basal and/or suprabasal
region.
Extraction of RNA
Total RNA from the hamster buccal pouch was extracted
using trizol reagent (Sigma) [14]. The RNA concentration
was determined from the optical density at a wavelength
of 260 nm (by using an OD260 unit equivalent to 40 μg/
ml of RNA). In brief, 50 mg pouch tissue was homoge-
nized using (1 ml) trizol reagent. The homogenate was
then treated with 0.2 ml of chloroform and shook vigor-
ously. The mixture was then centrifuged at 12,000 g for 15
min at 4°C. To the aqueous phase, 0.5 ml of isopropanol
was added, and centrifuged at 12,000 g for 8 minutes at
4°C. The supernatant was discarded gently and the precip-
itated RNA was rinsed twice with 1 ml of 75% ethanol and
dried in air. The RNA was resuspended in 100 μl of
diethylpyrocarbonate (Sigma) treated water at a final con-
centration of 1 μg/μl and stored at -80°C until further use.Journal of Carcinogenesis 2007, 6:19 http://www.carcinogenesis.com/content/6/1/19
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Reverse Transcriptase (RT) reaction: (cDNA synthesis)
Isolated total RNA (1 μg) was reverse-transcribed to cDNA
in a reaction mixture containing 4 μl of 5× reaction buffer,
2 μl of dNTPs mixture (10 mM), 20 units of RNase inhib-
itor, 200 units of avian-myeloblastosis virus (AMV)
reverse transcriptase and 0.5 μg of oligo(dT) primer
(Promega, WI, USA) in a total volume of 20 μl. The reac-
tion mixture was incubated at 42°C for 60 minutes and
the reaction terminated by heating at 70°C for 10 min-
utes. The resultant cDNA was stored at -80°C until further
use.
PCR amplification
All oligonucleotide primers were purchased from Sigma
Genosys, India. Details about the primers used for PCR
reactions are given in table 2. The primers for VEGF ampli-
fied two of four different molecular species produced by
alternative splicing of mRNA-VEGFI21 and VEGFI65 of
sizes 444 bp and 576 bp, respectively.
The PCR amplification reaction mixture (in a final volume
of 25 μl) contained 1 μl of cDNA, 0.5 μl of forward
primer, 0.5 μl of reverse primer and 10 μl of Hot Master
Mix (2.5×) (Eppendorf, Hamburg, Germany). The PCR
was carried out in a thermal cycler (Eppendorf, Hamburg,
Germany). Thermocycling conditions included initial
denaturation at 94°C for 5 minutes/10 minutes for VEGF
(one cycle), then denaturation at 95°C for 1 minute/30
seconds for VEGF, annealing at 55°C (1 minute) for cyclin
D1, GST-P, Bcl-2 and Bax, 51°C (30 seconds) for VEGF
and 60°C (1 minute) for β-actin, and extension at 72°C
(1 minute) for 30 cycles (40 cycles for VEGF) and a final
extension at 72°C for 7 minutes. Negative controls with-
out cDNA were also performed. Amplification products
were analysed by electrophoresis in a 2% agarose gel con-
taining ethidium bromide with 100 bp DNA ladder. The
PCR products were visualized as bands with a UV-transil-
luminator and photographs were taken using gel docu-
mentation system (Gel Doc Mega, United Kingdom).
SDS-PAGE and Western blot analysis
Approximately, 50 mg of each tissue sample was subjected
to lysis in a sample buffer containing 62.5 mM Tris (pH
6.8), 2% SDS, 5% 2-mercaptoethanol, 10% glycerol and
bromophenol blue. The protein concentration of lysates
was determined by Bradford method [15]. SDS-PAGE was
performed using equivalent protein extracts (55 μg) from
each sample according to Laemmli [16]. The resolved pro-
teins were electrophoretically transferred to polyvinyli-
dene difluoride membranes (Sartorius, Germany). The
membranes were incubated in 1× PBS containing 5%
non-fat dry milk for 2 h to block non-specific binding
sites. The blots were incubated with 1:400 dilution of
anti-NF-κB, Bcl-2, Bax, caspase-3, caspase-9, PARP and
VEGF (Santa Cruz Biotechnology) overnight at 4°C. The
blots were washed thrice with high salt buffer (2.18 g
NaH2PO4, 7 g Na2HPO4, 23.37 g NaCl and 200 μl Triton
×-100 in 400 ml distilled water) followed by low salt
buffer (2.18 g NaH2PO4, 7.03 g Na2HPO4, 1.2 g NaCl and
200 μl Triton ×-100 in 400 ml distilled water). The blots
were then incubated with 1:1000 dilution of horse radish
peroxidase-conjugated secondary antibodies (Santa Cruz
Biotechnology) for 45 minutes at room temperature. After
extensive washes with high and low salt buffers, the
immunoreactive proteins were visualized using enhanced
chemiluminescence (ECL) detection reagents (Sigma).
Densitometry was performed on IISP flat bed scanner and
quantitated with Total Lab 1.11 software.
Colorimetric estimation of caspase-3 activity
DEVD-specific caspase-3 activity was assayed using CASP-
3-C colorimetric kit (Sigma) according to the manufac-
turer's instructions. Cytosolic extracts were prepared by
homogenizing tissues in lysis buffer containing 50 mM
HEPES (pH 7.4), 5 mM CHAPS and 5 mM DTT. The
Table 2: Oligonucleotide primers used for RT-PCR of cyclin D1, GST-P, Bcl2, Bax and VEGF with β-actin as an internal control
Gene Product Primers Oligonucleotide sequences Fragment size
Cyclin D1 Sense Antisense 5'-CGGAGGACAACAAACAGATC-3'
5'-GGGTGTGCAAGCCAGGTCCA-3'
331 bp
GST-P Sense Antisense 5'-TCATCTACACCAACTATGAG-3'
5'-GCCACATAGGCAG AGAGCAG-3'
226 bp
Bcl-2 Sense Antisense 5'-TGCACCTGACGCCCTTCAC-3'
5'-AGACAGCCAGG AGAAATCA AACAG-3'
293 bp
Bax Sense Antisense 5'-ACCAAG CTGAGCGA GTGTC-3'
5'-ACAAAGATGGTCACGGTCTGCC-3'
374 bp
VEGF Sense Antisense 5'-ATGAACTTTCTGCTGTCTTGG-3'
5'-TCACCGCCTCGGCTTGTCACA-3'
444 bp and 576 bp*
β-actin Sense Antisense 5'-AACCGCGAGAAGATGACCCAGATCATGTTT-3'
5'-AGCAGCCGTGGCCATC TCTTGCTCGAAGTC-3'
350 bp
*The primers for VEGF detect two of four different molecular species produced by alternative splicing of mRNA-VEGFI21 and VEGFI65, with 
expected fragment sizes of 444 bp and 576 bp, respectively.Journal of Carcinogenesis 2007, 6:19 http://www.carcinogenesis.com/content/6/1/19
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supernatant was collected as an enzyme source. The cas-
pase-3 colorimetric assay is based on the hydrolysis of the
peptide substrate acetyl-Asp-Glu-Val-Asp-nitroanilide
(Ac-DEVD-pNA) by caspase-3, resulting in release of the
p-nitroaniline (pNA) moiety. The concentration of the
pNA released from the substrate is calculated from the
absorbance values at 405 nm or from a calibration curve
prepared with defined pNA solutions.
Statistical analysis
The data are expressed as mean ± SD. Tumour incidence
and grading of p21, GST-P, NF-κB, Bcl-2, Bax, cytochrome
C, caspase-3, cytokeratin and VEGF were statistically com-
pared using χ2-test. Statistical analysis on the data for
tumour burden was carried out using Student's t test. The
data for densitometric analysis, Bcl-2/Bax ratio and color-
imetric assay of caspase-3 were analysed using Analysis of
variance (ANOVA) followed by Least Significant Differ-
ence (LSD). The results were considered statistically signif-
icant if the p value was < 0.05.
Results
Table 3 shows the tumour incidence, mean tumour bur-
den and histopathological changes in experimental ani-
mals. The tumour incidence in group 1 was 100 per cent
with a mean tumour burden of 127 mm3. Histologically,
HBP tumours induced by DMBA were invasive squamous
cell carcinomas with papillary projections of squamous
epithelium into the connective tissues. Administration of
P-B and BTF-35 effectively suppressed the development of
HBP carcinomas. One of the 6 animals treated with
DMBA and P-B developed SCC, while 2 animals showed
mild to moderate dysplasia and remaining 3 hamsters dis-
played moderate hyperplasia. No tumours were observed
in animals treated with DMBA and BTF-35 while 2 out of
6 animals showed moderate hyperplasia. In groups 4–6,
the epithelium was normal, intact and continuous.
Figure 1 and Table 4 depict the immunohistochemical
analysis of p21, GST-P, NF-κB, cytokeratins and VEGF in
the hamster buccal pouch of control and experimental
animals. Topical application of DMBA (group 1) signifi-
cantly increased the expression of p21, GST-P, NF-κB,
cytokeratins and VEGF as compared to control (group 6).
In contrast to cytoplasmic staining of p21 in DMBA
painted animals, the pattern of p21 staining in P-B and
BTF-35 treated animals (groups 2 and 3), was predomi-
nantly in the nucleus with an occasional cell showing
cytoplasmic staining. Dietary administration of P-B and
BTF-35 significantly decreased the expression of GST-P,
NF-κB, cytokeratins and VEGF in groups 2 and 3 animals
compared to group 1. The expression of these proteins
was more significantly decreased in BTF-35 treated (group
3) animals compared to P-B treated (group 2) animals.
Administration of chemopreventive agents alone (groups
4 and 5) did not significantly influence protein expression
compared to untreated control (group 6).
The immunohistochemical expression of the apoptosis-
associated proteins Bcl-2, Bax, cytochrome C and caspase-
3 is shown in Figure 2 and Table 5. Topical application of
DMBA (group 1) significantly increased the expression of
Bcl-2 and decreased that of Bax, cytochrome C and cas-
pase-3 compared to control (group 6). Administration of
BTF-35 (group 3) decreased the expression of Bcl-2 and
increased expression of Bax, cytochrome C and caspase-3
more significantly than P-B (group 2) compared to group
1 animals. No significant changes in the expression of
proteins were observed in groups 4 and 5 as compared to
control.
Figure 3 shows the representative RT-PCR data of cyclin
D1, GST-P, Bcl-2, Bax and VEGF in the buccal pouch of
control and experimental animals. Quantification of each
band by densitometric scanning shows significant
increase in the expression of cyclin D1, GST-P, Bcl-2 and
VEGF with decreased expression of Bax in DMBA painted
hamsters (group 1) compared to untreated control.
Although both P-B and BTF-35 significantly decreased cyc-
lin D1, GST-P, VEGF expression and Bcl-2/Bax ratio com-
pared to group 1 animals, BTF-35 was more effective. No
significant changes in the mRNA expression of cyclin D1,
Table 3: Tumour incidence, tumour burden and histopathological changes in the buccal pouch of experimental animals (mean ± SD; n 
= 6)
Group Treatment Tumour incidence Tumour burdena mm3 Hyperplasia Dysplasia Squamous cell carcinoma
1. DMBA 6/6 127.21 ± 87.42 +++ +++ # (100%)
2. DMBA+ P-B 1/6 b 8.31 ± 7.92c ++ +/++ # (16.6%)b
3. DMBA+ BTF-35 0/6d -+ - -
4C o n t r o l 0 / 6 - - - -
+ = mild; ++ = moderate; +++ = severe; # = well differentiated; - = no change; Parentheses, percentage of lesions
a – Mean tumour burden was calculated by multiplying the mean tumour volume with the mean number of tumours (tumour volume was calculated 
using 4/3 πr3, where r = 1/2 tumour diameter in mm)
b – Significantly different from group 1 by χ2-test (p < 0.05)
c – Significantly different from group 1 by Student's t test (p < 0.001)
d – Significantly different from group 1 by χ2-test (p < 0.001)Journal of Carcinogenesis 2007, 6:19 http://www.carcinogenesis.com/content/6/1/19
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GST-P, Bcl-2, Bax and VEGF were observed in animals
treated with chemopreventive agents alone as compared
to control.
Figure 4 shows representative Western blot analysis of NF-
κB, VEGF, Bcl-2, Bax, caspase-3, caspase-9, and PARP and
the activity of DEVD-specific caspase-3 in the buccal
pouch of control and experimental animals. The expres-
sion of NF-κB, VEGF, Bcl-2, Bax and caspase-9 was
detected as bands of molecular weight, 65, 21, 25, 21 and
48 kDa respectively. The expression of caspase-3 was
detected as bands of molecular weight 35 kDa and 20 kDa
and that of PARP was detected as a band of molecular
weight 116 kDa and a cleaved product of molecular
weight 85 kDa. The mean expression from control lysates
was designated as 100% in the graph. Each bar represents
the mean protein expression ± SD of 6 determinations per
treatment. Topical application of DMBA significantly
increased the expression of NF-κB, VEGF and Bcl-2 and
decreased Bax, caspases -3, caspase-9, and PARP expres-
sion as well as caspase-3 activity compared to untreated
control. Dietary administration of both P-B and BTF-35 to
DMBA painted animals (groups 2 and 3) significantly
decreased the expression of NF-κB, VEGF and Bcl-2 and
increased the expression of Bax, caspase-3, caspase-9,
PARP and its cleaved product as well as caspase-3 activity
compared to group 1. However, modulation of protein
expression and increase in caspase-3 activity was more sig-
nificant in BTF-35 treated (group 3) animals compared to
the P-B treated hamsters (group 2). In animals adminis-
tered P-B and BTF-35 alone (groups 4 and 5), protein
expression and the activity of caspase-3 were not signifi-
cantly different as compared to untreated control.
Discussion
In the present study, topical application of DMBA to the
hamster cheek pouch for 14 weeks induced squamous cell
carcinomas that displayed increased cell proliferation,
infiltrative and angiogenic potential coupled with apopto-
sis evasion. Overexpression of cyclin D1, p21, GST-P, and
NF-κB in HBP carcinomas is consistent with similar find-
ings in DMBA-induced experimental tumours and in
human OSCC reported in literature [17-21]. In particular,
DMBA is known to induce the expression of GST-P and
NF-κB [17,18]. Induction of GST-P is believed to facilitate
cell proliferation and inhibit apoptosis leading to clonal
expansion and malignant transformation [18]. p21, a crit-
ical downstream mediator of wild type p53 regulates sev-
eral cell cycle proteins including cyclin D1, inhibits cyclin-
dependent kinases (CDKs) and induces cell cycle arrest
[22]. Although this implies downregulation of p21
expression in tumour cells, several reports including the
present one have demonstrated overexpression of p21 in
the cytoplasm of rapidly proliferating tumours [23,24].
These observations suggest that nuclear localization is
essential for p21 to function as a CDK inhibitor. Upregu-
lation of both p21 and cyclin D1 has been reported in sev-
eral tumours including OSCCs [25,26]. In addition to cell
cycle regulation, p21 also has a role in cell survival. Akita
et al [27] demonstrated that p21waf1 stimulates constitu-
tive activation of NF-κB signaling in W4 cells independent
of Rel A nuclear localization. Thus cytoplasmic colocaliza-
tion and overexpression of p21 and NF-κB in HBP
tumours may be interrelated and indicative of increased
cell proliferation and cell survival.
In addition to their regulatory role in the cell cycle, GST-
P, NF-κB and p21 also inhibit apoptosis by interacting
with procaspase-3 and increasing the Bcl-2/Bax ratio [28].
Overexpression of Bcl-2 observed in HBP tumours in the
Table 4: Cellular localization of p21 and expression of GST-P, NF-κB, cytokeratin and VEGF in the buccal pouch of experimental and 
control animals (n = 6)
Group Treatment Cellular localization of 
p21 protein
p21a GST-Pa NF-κBa Cytokeratinb VEGFa
Cytoplasm Nucleus 0 1 2 3 0 1 2 3 0 1 2 3 I II III 0 1 2 3
1. DMBA 85%c <5%c 00240 c 015 c 0c 015 c 00 c 6c 0006 c
2. DMBA+P- B 5%d 73%d 0033 3 120 d 01 50 d 04 20330 d
3. DMBA+BTF-35 <5%d 75%d 0024 4 200 d 04 20 d 05 d 1d 05 d 10 d
4 . P - B - - 6000 6 00 0 6 00 0 0 6 0 0 3 3 0
5. BTF-35 - - 6 0 0 0 6 0 0 0 6 0 0 0 0 6 0 0 2 40
6. Control - - 6 0 0 0 6 0 0 0 6 0 0 0 0 6 0 0 2 4 0
a – Expression scored as 0- negative; 1- focal and mildly intense; 2- between one-third and two-third of cells stained moderately, and 3- majority of 
cells (> two third) stained intensely
b – Expression graded as 0 = failure to detect the keratin, I = staining confined either to the basal area or some evidence of suprabasal staining, II = 
positive staining throughout the basal and/or suprabasal region.
c – Significantly different from group 6 by χ2-test (p < 0.05)
d – Significantly different from group 1 by χ2-test (p < 0.05)Journal of Carcinogenesis 2007, 6:19 http://www.carcinogenesis.com/content/6/1/19
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present study can block mitochondrial mediated apopto-
sis by preventing the release of apoptogenic factors such as
cytochrome C, thereby inhibiting activation of caspases–9
and -3, as well as cleavage of PARP, a nuclear enzyme
involved in DNA repair and maintenance of genomic
integrity. The antiapoptotic protein Bcl-2 is also recog-
nized to act as a proangiogenic signaling molecule and
potentiate NF-κB-mediated angiogenesis [29]. The proan-
giogenic factor VEGF in turn induces endothelial cell pro-
liferation and Bcl-2 mediated cell survival [30]. Increased
cell proliferation together with apoptosis evasion and
neovascularization can facilitate tumour infiltration in
HBP carcinomas as evidenced by overexpression of cytok-
eratins. The results of the present study demonstrate that
cell proliferation, apoptosis, and angiogenesis are intri-
cately interlinked in malignant transformation of the HBP
mucosa by DMBA. Overexpression of Bcl-2, cytokeratins,
and VEGF with downregulation of Bax, cytochrome C,
caspase-3, caspase-9 and PARP may confer a survival
advantage to HBP carcinomas by acquisition of an apop-
tosis-resistant, invasive and angiogenic phenotype.
Dietary administration of P-B and BTF-35 for 18 weeks
starting from 4 weeks prior to DMBA exposure reduced
the incidence of HBP carcinomas and preneoplastic
lesions. The inhibitory effect of P-B and BTF-35 on HBP
carcinogenesis was associated with enhanced nuclear
expression of p21 and downregulation of NF-κB and GST-
P expression. Studies have demonstrated that tea polyphe-
nols exert their growth inhibitory effects on cancer cell
lines by inducing p21 [31,32]. Nuclear localization of p21
induced by black tea polyphenols in the present study
Photomicrographs of immunohistochemical staining of p21, GST-P, NF-κB, cytokeratins and VEGF in control and experimental  animals Figure 1
Photomicrographs of immunohistochemical staining of p21, GST-P, NF-κB, cytokeratins and VEGF in control and experimental 
animals. A Increased cytoplasmic expression of p21 in group 1 animals B & C Increased nuclear expression of p21 in groups 2 
and 3 animals, D Normalexpression of p21 in groups 4, 5 and 6 animals, E Overexpression, ofGST-P in group 1 animals, F & G 
Downregulation of GST-P in groups 2 and 3 animals, H Normal expression of GST-P in groups 4, 5 and 6 animals, I Overex-
pression of NF-κB in group 1 animals, J & K Downregulation of NF-κB in groups 2 and 3 animals, L Normal expression of NF-
κB ingroups 4, 5 and 6 animals, M, Overexpression of cytokeratins in group1 animals, N &O Downregulation of cytokeratins in 
groups 2 and 3 animals, P Normal expression of cytokeratins in groups 4, 5 and 6 animals, Q Overexpression of VEGF in group 
1 animals, R& S Downregulation of VEGF in groups 2 and 3 animals, T Normal expression of VEGF in groups 4, 5 and 6 animals.Journal of Carcinogenesis 2007, 6:19 http://www.carcinogenesis.com/content/6/1/19
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may facilitate cell cycle arrest by direct interaction with
cyclin/CDK complex [33]. Although induction of p21
coincided with the impaired expression of cyclin D1, a
study on CDK inhibitors suggests that p21 fails to inhibit
cyclin D-CDK when bound to this complex at 1:1 ratio
[34]. Therefore, in the present study p21 may decrease the
expression of cyclin D1 through some indirect mecha-
nism that needs to be elucidated. Consistent with our
findings, Liberto and Cobrinik [35] demonstrated simul-
taneous induction of p21 expression with inhibition of
cyclin D1-mediated pRB phosphorylation in MCF cells by
EGCG. In addition to the effects on cell cycle regulators,
tea has also been reported to downregulate NF-κB and
GST-P in cell lines and animal tumour models [36,37].
Banerjee et al [38] found a positive correlation between
the antiproliferative and proapoptotic effects of black tea
polyphenols during benzo [a]pyrene-induced lung car-
cinogenesis. The decrease in Bcl-2/Bax ratio, a reliable
Photomicrographs of immunohistochemical staining of Bcl-2, Bax, cytochrome C and caspase 3 in control and experimental  animals Figure 2
Photomicrographs of immunohistochemical staining of Bcl-2, Bax, cytochrome C and caspase 3 in control and experimental 
animals. A Overexpression of Bcl-2 in group 1 animals B&C Downregulation of Bcl-2 in groups 2 and 3 animals, D Normal 
expression of Bcl-2 in groups 4, 5 and 6 animals, E Downregulation of Bax in group 1 animals, F&G Increasedexpression of Bax 
in groups 2 and 3 animals, H Normal, expression of Bax in groups 4, 5 and 6 animals, I Downregulation of cytochrome C in 
group 1 animals, J &K Increased expression of cytochrome C in groups 2 and 3 animals, L Normal expression of cytochrome C 
in groups 4, 5 and 6 animals, M, Downregulation of caspase-3 in group 1 animals, N &O Increased expression of caspase-3 in 
groups 2 and 3 animals, P Normal expression of caspase-3 in groups 4, 5 and 6 animals.Journal of Carcinogenesis 2007, 6:19 http://www.carcinogenesis.com/content/6/1/19
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indicator of the overall propensity of a cell to undergo
apoptosis coupled with overexpression of cytochrome C,
caspases-9, -3 and cleavage of PARP by P-B and BTF-35 in
the present study strengthens the apoptosis inducing
potential of black tea polyphenols reported in cell lines
and animal models by other workers [39-42].
The antiproliferative and apoptosis inducing effects of P-
B and BTF-35 seen in the present study could potentially
mitigate the carcinogenic effects of DMBA thereby
decreasing the infiltrative and angiogenic potential of
HBP carcinomas as reflected by decreased cytokeratin and
VEGF expression. A previous study from this laboratory
demonstrated a positive association between downregula-
tion of cytokeratin AE1/AE3 expression and inhibition of
HBP carcinogenesis by lactoferrin and black tea polyphe-
nol combination [10]. Tea polyphenols have been
reported to inhibit angiogenesis by downregulating VEGF
expression [43].
Conclusion
The results of the present study provide evidence that P-B
and BTF-35 act as suppressing agents by inhibiting cell
proliferation, tumour cell survival, infiltration and angio-
genesis, and inducing apoptosis. An interesting finding in
the present study is the differential sensitivities of HBP
carcinomas and normal pouch to growth control and
apoptosis induction by P-B and BTF-35. Administration of
P-B and BTF-35 selectively induced apoptosis in DMBA
painted hamsters but not in normal animals. Tea
polyphenols such as EGCG and theaflavins have been
demonstrated to induce apoptosis of tumour cells while
sparing normal cells [44,45]. Taken together, these find-
ings potentiate the fact that diet-derived agents such as P-
B and BTF-35 that drive tumour cells to undergo apoptosis
but direct normal cells towards a survival pathway are
ideal chemopreventives.
The greater efficacy of BTF-35 may be attributed to the
higher content of theaflavins and low caffeine. Theafla-
vins have been reported to act on multiple signal trans-
duction pathways resulting in induction of apoptosis and
suppression of NF-κB and COX-2 expression [41]. Low
dose caffeine has been reported to be more beneficial than
higher doses in suppressing cell proliferation and induc-
ing apoptosis in cancer cell lines [46,47]. The results of the
present study suggest that BTF-35 may have an immense
potential in human oral cancer prevention. However,
additional studies on the effect of BTF-35 on a wide range
of cell cycle associated proteins, NF-κB signaling path-
ways, Bcl-2 family proteins, caspases, and angiogenic
chemokines are required to unravel the differential
response of BTF-35 in normal versus cancer cells and con-
firm the mechanistic pathways of chemoprevention.
Abbreviations
CDK – cyclin-dependent kinase
DMBA – 7,12-dimethylbenz [a]anthracene
GST-P – glutathione S-transferase-pi
HBP – hamster buccal pouch
NF-κB – nuclear factor kappa B
OSCC – oral squamous cell carcinoma
PARP – poly(ADP-ribose)polymerase
P-B – Polyphenon-B
Table 5: Effect of P-B and BTF-35 on the expression of Bcl-2, Bax, cytochrome C and caspase-3 in experimental and control animals (n 
= 6)
Group Treatment Gradinga
Bcl-2 Bax Cytochrome C Caspase-3
0123012301230123
1. DMBA 0b 015 b 6b 00060005100
2. DMBA+P-B 1c 410 c 0c 0240 c 15 c 20 c 132
3. DMBA+BTF-35 1 5c 000 c 015 c 0c 06 c 40 c 024
4 . P - B 5100240042003300
5 . B T F - 3 5 6000150033002400
6 . C o n t r o l 6000240033002400
a – Expression scored as 0- negative; 1- focal and mildly intense; 2- between one-third and two-third of cells stained moderately, and 3- majority of 
cells (> two third) stained intensely
b – Significantly different from group 6 by χ2-test (p < 0.05)
c – Significantly different from group 1 by χ2-test (p < 0.05)Journal of Carcinogenesis 2007, 6:19 http://www.carcinogenesis.com/content/6/1/19
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The effect of P-B and BTF-35 on the mRNA expression of cyclin D1, GST-P VEGF, Bcl-2, Bax, and Bcl-2/Bax ratio in the buccal  pouch of control and experimental animals Figure 3
The effect of P-B and BTF-35 on the mRNA expression of cyclin D1, GST-P VEGF, Bcl-2, Bax, and Bcl-2/Bax ratio in the buccal 
pouch of control and experimental animals. (Mean ± SD; n = 6). (A) RT-PCR analyses of cyclin D1, GST-P, Bcl-2, Bax, and 
VEGF. β-actin inserted as a control (B) Densitometric analysis. ♣ Significantly different from untreated control (p < 0.001) ♣♣ 
Significantly different from untreated control (p < 0.0001) * Significantly different from group 1 animals (p < 0.001) ** Signifi-
cantly different from group 1 animals (p < 0.0001).
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The effect of P-B and BTF-35 on NF-κB, VEGF, Bcl-2, Bax, caspase-3, caspase-9, and ARP expression and caspase-3 activity in  the buccal pouch of control and experimental animals (Mean ± SD; n = 6) Figure 4
The effect of P-B and BTF-35 on NF-κB, VEGF, Bcl-2, Bax, caspase-3, caspase-9, and ARP expression and caspase-3 activity in 
the buccal pouch of control and experimental animals (Mean ± SD; n = 6). A) Representative immunoblots of NF-κB, VEGF, 
Bcl-2, Bax, caspase-3, caspase-9, and PARP (The intact caspase-3 (35 kDa) and a cleavage fragment (20 kDa) as well as the 
intact PARP (116 kDa) and a PARP cleavage fragment (85 kDa) are indicated). (B) Densitometric analysis. ♣ Significantly differ-
ent from untreated control (p < 0.01), ♣♣ Significantly different from untreated control (p < 0.001)* Significantly different 
from group 1 animals (p < 0.01), ** Significantly different from group 1 animals (p < 0.001), *** Significantly different from group 
1 animals (p < 0.0001)U# – μmoles of pNA formed/min.
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VEGF – vascular endothelial growth factor
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